Vitamin D and Cardiovascular Risk

[1]  C. Mathieu,et al.  Straight from D-Heart: vitamin D status and cardiovascular disease , 2012, Current opinion in lipidology.

[2]  E. Ford,et al.  Serum 25-hydroxyvitamin D levels and all-cause and cardiovascular disease mortality among US adults with hypertension: the NHANES linked mortality study , 2012, Journal of hypertension.

[3]  Dhanunjaya R. Lakkireddy,et al.  Vitamin D deficiency and supplementation and relation to cardiovascular health. , 2012, The American journal of cardiology.

[4]  S. Pilz,et al.  Vitamin D deficiency and mortality risk in the general population: a meta-analysis of prospective cohort studies. , 2012, The American journal of clinical nutrition.

[5]  J. Manson,et al.  A prospective study of serum 25-hydroxyvitamin D levels, blood pressure, and incident hypertension in postmenopausal women. , 2012, American journal of epidemiology.

[6]  R. Boston,et al.  Vitamin D3 supplementation improves insulin sensitivity in subjects with impaired fasting glucose. , 2011, Translational research : the journal of laboratory and clinical medicine.

[7]  B. Zinman,et al.  Prospective Associations of Vitamin D With β-Cell Function and Glycemia , 2011, Diabetes.

[8]  V. Hirani.  Relationship Between Vitamin D and Hyperglycemia in Older People From a Nationally Representative Population Survey , 2011, Journal of the American Geriatrics Society.

[9]  C. Sabanayagam,et al.  Serum Vitamin D Level and Prehypertension among Subjects Free of Hypertension , 2011, Kidney and Blood Pressure Research.

[10]  C. McCarty,et al.  Diabetes prevalence is associated with serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D in US middle-aged Caucasian men and women: a cross-sectional analysis within the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. , 2011, The British journal of nutrition.

[11]  F. Hu,et al.  Effects of vitamin D and calcium supplementation on pancreatic β cell function, insulin sensitivity, and glycemia in adults at high risk of diabetes: the Calcium and Vitamin D for Diabetes Mellitus (CaDDM) randomized controlled trial. , 2011, The American journal of clinical nutrition.

[12]  J. Manson,et al.  Vitamin D intake and risk of cardiovascular disease in US men and women. , 2011, The American journal of clinical nutrition.

[13]  J. Mitri,et al.  Vitamin D and type 2 diabetes: a systematic review , 2011, European Journal of Clinical Nutrition.

[14]  V. Montori,et al.  Vitamin D and cardiovascular outcomes: a systematic review and meta-analysis. , 2011, The Journal of clinical endocrinology and metabolism.

[15]  C. Gordon,et al.  Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. , 2011, The Journal of clinical endocrinology and metabolism.

[16]  J. Shaw,et al.  Serum 25-Hydroxyvitamin D, Calcium Intake, and Risk of Type 2 Diabetes After 5 Years , 2011, Diabetes Care.

[17]  S. Larsson,et al.  Blood 25-hydroxyvitamin D concentration and hypertension: a meta-analysis , 2011, Journal of hypertension.

[18]  P. Leung,et al.  A novel role for vitamin D: modulation of expression and function of the local renin–angiotensin system in mouse pancreatic islets , 2011, Diabetologia.

[19]  P. Hopkins,et al.  25-Hydroxyvitamin D is associated with plasma renin activity and the pressor response to dietary sodium intake in Caucasians , 2011, Journal of the renin-angiotensin-aldosterone system : JRAAS.

[20]  J. Hokanson,et al.  Vitamin D Deficiency and Coronary Artery Calcification in Subjects With Type 1 Diabetes , 2011, Diabetes Care.

[21]  B. Zinman,et al.  Association of vitamin D with insulin resistance and β-cell dysfunction in subjects at risk for type 2 diabetes. Diabetes Care 2010;33:1379―1381 , 2011 .

[22]  M. Bissell.  25-Hydroxyvitamin D Levels Inversely Associate with Risk for Developing Coronary Artery Calcification , 2011 .

[23]  Daniel L. Koller,et al.  Association of the Vitamin D Metabolism Gene CYP24A1 With Coronary Artery Calcification , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[24]  A. Vaidya,et al.  Vitamin D and Hypertension: Current Evidence and Future Directions , 2010, Hypertension.

[25]  B. Horne,et al.  Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population. , 2010, The American journal of cardiology.

[26]  C. Flück,et al.  High prevalence of vitamin D deficiency in children and adolescents with type 1 diabetes. , 2009, Swiss medical weekly.

[27]  J. Manson,et al.  Plasma 25-Hydroxyvitamin D Concentration and Risk of Incident Type 2 Diabetes in Women , 2010, Diabetes Care.

[28]  G. Ghirlanda,et al.  No Protective Effect of Calcitriol on β-Cell Function in Recent-Onset Type 1 Diabetes , 2010, Diabetes Care.

[29]  W. März,et al.  Vitamin D deficiency is associated with sudden cardiac death, combined cardiovascular events, and mortality in haemodialysis patients , 2010, European heart journal.

[30]  S. Ho,et al.  Effects of Vitamin D Supplementation on Blood Pressure , 2010, Southern medical journal.

[31]  A. Morris,et al.  The effect of different doses of vitamin D3 on markers of vascular health in patients with type 2 diabetes: a randomised controlled trial , 2010, Diabetologia.

[32]  Jennifer G. Robinson,et al.  Calcium/vitamin D supplementation and coronary artery calcification in the Women's Health Initiative , 2010, Menopause.

[33]  A. Pontecorvi,et al.  Association of Vitamin D With Insulin Resistance and β-Cell Dysfunction in Subjects at Risk for Type 2 Diabetes , 2010, Diabetes Care.

[34]  S. Mihaila.  Vitamin D deficiency is associated with sudden cardiac death, combined cardiovascular events, and mortality in haemodialysis patients. , 2010, Maedica.

[35]  D. Deb,et al.  Vitamin D receptor attenuates renal fibrosis by suppressing the renin-angiotensin system. , 2010, Journal of the American Society of Nephrology : JASN.

[36]  R. Jorde,et al.  No improvement in cardiovascular risk factors in overweight and obese subjects after supplementation with vitamin D3 for 1 year , 2010, Journal of internal medicine.

[37]  E. Bonifacio,et al.  No Effect of the 1α,25-Dihydroxyvitamin D3 on β-Cell Residual Function and Insulin Requirement in Adults With New-Onset Type 1 Diabetes , 2010, Diabetes Care.

[38]  N. Shah,et al.  Pilot study to evaluate the effect of short-term improvement in vitamin D status on glucose tolerance in patients with type 2 diabetes mellitus. , 2010, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[39]  B. Zinman,et al.  Association of Vitamin D With Insulin Resistance and β-Cell Dysfunction in Subjects at Risk for Type 2 Diabetes , 2010, Diabetes Care.

[40]  T. Trikalinos,et al.  Systematic Review: Vitamin D and Cardiometabolic Outcomes , 2010, Annals of Internal Medicine.

[41]  O. Franco,et al.  Levels of vitamin D and cardiometabolic disorders: systematic review and meta-analysis. , 2010, Maturitas.

[42]  S. Keller,et al.  Valsartan Protects Pancreatic Islets and Adipose Tissue From the Inflammatory and Metabolic Consequences of a High-Fat Diet in Mice , 2010, Hypertension.

[43]  R. Jorde,et al.  Serum 25-Hydroxyvitamin D Levels Are Strongly Related to Systolic Blood Pressure But Do Not Predict Future Hypertension , 2010, Hypertension.

[44]  P. Toth.  1,25(OH)2 Vitamin D Inhibits Foam Cell Formation and Suppresses Macrophage Cholesterol Uptake in Patients With Type 2 Diabetes Mellitus , 2010 .

[45]  J. Sugden,et al.  The effect of different doses of vitamin D3 on markers of vascular health in patients with type 2 diabetes: a randomised controlled trial , 2010, Diabetologia.

[46]  C. Camargo,et al.  Relation of serum 25-hydroxyvitamin D to heart rate and cardiac work (from the National Health and Nutrition Examination Surveys). , 2010, The American journal of cardiology.

[47]  A. Struthers,et al.  Effect of vitamin D on blood pressure: a systematic review and meta-analysis , 2009, Journal of hypertension.

[48]  J. Coad,et al.  Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient – a randomised, placebo-controlled trial , 2009, British Journal of Nutrition.

[49]  Carlos A Camargo,et al.  Prospective Study of Serum 25‐Hydroxyvitamin D Level, Cardiovascular Disease Mortality, and All‐Cause Mortality in Older U.S. Adults , 2009, Journal of the American Geriatrics Society.

[50]  K. Schechtman,et al.  1,25(OH)2 Vitamin D Inhibits Foam Cell Formation and Suppresses Macrophage Cholesterol Uptake in Patients With Type 2 Diabetes Mellitus , 2009, Circulation.

[51]  M. Chonchol,et al.  25-Hydroxyvitamin D deficiency is independently associated with cardiovascular disease in the Third National Health and Nutrition Examination Survey. , 2009, Atherosclerosis.

[52]  Xiang Yan,et al.  Protective effects of 1‐α‐hydroxyvitamin D3 on residual β‐cell function in patients with adult‐onset latent autoimmune diabetes (LADA) , 2009, Diabetes/metabolism research and reviews.

[53]  J. Manson,et al.  Calcium plus vitamin D supplementation and mortality in postmenopausal women: the Women's Health Initiative calcium-vitamin D randomized controlled trial. , 2009, The journals of gerontology. Series A, Biological sciences and medical sciences.

[54]  Carlos A Camargo,et al.  Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004. , 2009, Archives of internal medicine.

[55]  G. Curhan,et al.  Plasma 25-Hydroxyvitamin D Levels and Risk of Incident Hypertension Among Young Women , 2008, Hypertension.

[56]  J. Manson,et al.  Effect of Calcium and Vitamin D Supplementation on Blood Pressure: The Women's Health Initiative Randomized Trial , 2008, Hypertension.

[57]  W. März,et al.  Association of vitamin D deficiency with heart failure and sudden cardiac death in a large cross-sectional study of patients referred for coronary angiography. , 2008, The Journal of clinical endocrinology and metabolism.

[58]  K. Cao,et al.  Calcium-independent and 1,25(OH)2D3-dependent regulation of the renin-angiotensin system in 1alpha-hydroxylase knockout mice. , 2008, Kidney international.

[59]  Stefan Pilz,et al.  Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality. , 2008, Archives of internal medicine.

[60]  E. Rimm,et al.  25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. , 2008, Archives of internal medicine.

[61]  P. Leung,et al.  Effects of hyperglycemia on angiotensin II receptor type 1 expression and insulin secretion in an INS-1E pancreatic beta-cell line. , 2008, JOP : Journal of the pancreas.

[62]  J. Manson,et al.  Dietary Intake of Dairy Products, Calcium, and Vitamin D and the Risk of Hypertension in Middle-Aged and Older Women , 2008, Hypertension.

[63]  A. Akobeng,et al.  Vitamin D supplementation in early childhood and risk of type 1 diabetes: a systematic review and meta-analysis , 2008, Archives of Disease in Childhood.

[64]  Michael J. Pencina,et al.  Vitamin D Deficiency and Risk of Cardiovascular Disease , 2008, Circulation.

[65]  C. Mathieu,et al.  Unaltered Diabetes Presentation in NOD Mice Lacking the Vitamin D Receptor , 2008, Diabetes.

[66]  B. Kestenbaum,et al.  Calcium plus vitamin D supplementation and the risk of incident diabetes mellitus in the Women ’ s Health Initiative , 2008 .

[67]  M. García-Arencibia,et al.  Genomic actions of 1,25-dihydroxyvitamin D3 on insulin receptor gene expression, insulin receptor number and insulin activity in the kidney, liver and adipose tissue of streptozotocin-induced diabetic rats , 2008, BMC Molecular Biology.

[68]  Wei Zheng,et al.  1,25-Dihydroxyvitamin D3 Suppresses Renin Gene Transcription by Blocking the Activity of the Cyclic AMP Response Element in the Renin Gene Promoter* , 2007, Journal of Biological Chemistry.

[69]  Sara Gandini,et al.  Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. , 2007, Archives of internal medicine.

[70]  M. Holick.  Vitamin D deficiency. , 2007, The New England journal of medicine.

[71]  M. Sowers,et al.  Serum 25-hydroxyvitamin D, ethnicity, and blood pressure in the Third National Health and Nutrition Examination Survey. , 2007, American journal of hypertension.

[72]  A. Mitrakou,et al.  The Effects of Calcium and Vitamin D Supplementation on Blood Glucose and Markers of Inflammation in Nondiabetic Adults , 2007, Diabetes Care.

[73]  Keith C. Norris,et al.  Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey. , 2007, Archives of internal medicine.

[74]  Bess Dawson-Hughes,et al.  The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. , 2007, The Journal of clinical endocrinology and metabolism.

[75]  Edward Giovannucci,et al.  Plasma 25-Hydroxyvitamin D Levels and Risk of Incident Hypertension , 2007, Hypertension.

[76]  J. Manson,et al.  Calcium/Vitamin D Supplementation and Cardiovascular Events , 2007, Circulation.

[77]  E. Ritz,et al.  Demonstration of 1,25(OH)2 vitamin D3 receptors and actions in vascular smooth muscle cellsIn vitro , 1987, Calcified Tissue International.

[78]  L. Nyström,et al.  Lower levels of plasma 25-hydroxyvitamin D among young adults at diagnosis of autoimmune type 1 diabetes compared with control subjects: results from the nationwide Diabetes Incidence Study in Sweden (DISS) , 2006, Diabetologia.

[79]  P. Pozzilli,et al.  The effects of calcitriol and nicotinamide on residual pancreatic β‐cell function in patients with recent‐onset Type 1 diabetes (IMDIAB XI) , 2006, Diabetic medicine : a journal of the British Diabetic Association.

[80]  W. Willett,et al.  Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. , 2006, The American journal of clinical nutrition.

[81]  J. Manson,et al.  Vitamin D and calcium intake in relation to type 2 diabetes in women. , 2006, Diabetes care.

[82]  P. Leung,et al.  Angiotensin II type 1 receptor blockade improves beta-cell function and glucose tolerance in a mouse model of type 2 diabetes. , 2006, Diabetes.

[83]  P. Leung,et al.  Angiotensin II type 1 receptor blockade improves beta-cell function and glucose tolerance in a mouse model of type 2 diabetes. , 2006, Diabetes.

[84]  N. Stern,et al.  25-Hydroxyvitamin D3-1α-Hydroxylase Is Expressed in Human Vascular Smooth Muscle Cells and Is Upregulated by Parathyroid Hormone and Estrogenic Compounds , 2005, Circulation.

[85]  C. Mathieu,et al.  1,25-Dihydroxyvitamin D3 modulates expression of chemokines and cytokines in pancreatic islets: implications for prevention of diabetes in nonobese diabetic mice. , 2005, Endocrinology.

[86]  M. Sowers,et al.  Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey. , 2004, Diabetes care.

[87]  M. Hewison,et al.  Expression of 25-hydroxyvitamin D3-1α-hydroxylase in pancreatic islets , 2004, The Journal of Steroid Biochemistry and Molecular Biology.

[88]  M. Saad,et al.  Hypovitaminosis D is associated with insulin resistance and β cell dysfunction , 2004 .

[89]  M. Hewison,et al.  Expression of 25-hydroxyvitamin D3-1alpha-hydroxylase in pancreatic islets. , 2004, The Journal of steroid biochemistry and molecular biology.

[90]  C. Mathieu,et al.  Prevention of autoimmune diabetes in NOD mice by 1,25 dihydroxyvitamin D3 , 1994, Diabetologia.

[91]  L. C. Stene,et al.  Use of cod liver oil during the first year of life is associated with lower risk of childhood-onset type 1 diabetes: a large, population-based, case-control study. , 2003, The American journal of clinical nutrition.

[92]  P. Leung,et al.  A local pancreatic renin-angiotensin system: endocrine and exocrine roles. , 2003, The international journal of biochemistry & cell biology.

[93]  L. Dakovska,et al.  THE EFFECT OF VITAMIN D3 ON INSULIN SECRETION AND PERIPHERAL INSULIN SENSITIVITY IN TYPE 2 DIABETIC PATIENTS , 2003, International journal of clinical practice.

[94]  E. Wolf,et al.  Impaired insulin secretory capacity in mice lacking a functional vitamin D receptor , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[95]  M. Holick.  Vitamin D: A millenium perspective , 2003, Journal of cellular biochemistry.

[96]  M. Holick.  VITAMIN D: A MILLENNIUM PERSPECTIVE , 2003 .

[97]  T. Shinki,et al.  Characterization of transgenic rats constitutively expressing vitamin D-24-hydroxylase gene. , 2002, Biochemical and biophysical research communications.

[98]  N. Dávila,et al.  Transcriptional activation of the human insulin receptor gene by 1,25‐dihydroxyvitamin D3 , 2002, Cell biochemistry and function.

[99]  Shu Q. Liu,et al.  1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system , 2002 .

[100]  M. Uskoković,et al.  A 1α,25-Dihydroxyvitamin D3 Analog Enhances Regulatory T-Cells and Arrests Autoimmune Diabetes in NOD Mice , 2002 .

[101]  B. Dawson-Hughes,et al.  Serum 25-hydroxyvitamin D status of adolescents and adults in two seasonal subpopulations from NHANES III. , 2002, Bone.

[102]  M. Uskoković,et al.  A 1alpha,25-dihydroxyvitamin D(3) analog enhances regulatory T-cells and arrests autoimmune diabetes in NOD mice. , 2002, Diabetes.

[103]  Shu Q. Liu,et al.  1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. , 2002, The Journal of clinical investigation.

[104]  Elina Hyppönen,et al.  Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study , 2001, The Lancet.

[105]  H. Minne,et al.  Effects of a short-term vitamin D(3) and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women. , 2001, The Journal of clinical endocrinology and metabolism.

[106]  J. Campión,et al.  Stimulation by 1,25-dihydroxyvitamin D3 of insulin receptor expression and insulin responsiveness for glucose transport in U-937 human promonocytic cells. , 2000, Endocrine journal.

[107]  S. Plaeger,et al.  Current evidence and future directions for targeting HIV entry: therapeutic and prophylactic strategies. , 2000, JAMA.

[108]  C. Beaufort.  The EURODIAB Substudy 2 Study Group Vitamin D supplement in early childhood and risk for Type I (insulin-dependent) diabetes mellitus , 1999 .

[109]  B. Billaudel,et al.  Influence of vitamin D3 deficiency and 1,25 dihydroxyvitamin D3 on de novo insulin biosynthesis in the islets of the rat endocrine pancreas. , 1999, The Journal of endocrinology.

[110]  K. Watson,et al.  Active serum vitamin D levels are inversely correlated with coronary calcification. , 1997, Circulation.

[111]  S. Zanello,et al.  Vitamin D receptor expression in chicken muscle tissue and cultured myoblasts. , 1997, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[112]  A. K. Jarvis,et al.  1,25-Dihydroxyvitamin D3 regulation of cardiac myocyte proliferation and hypertrophy. , 1997, The American journal of physiology.

[113]  K. Khaw,et al.  Effect of winter oral vitamin D3 supplementation on cardiovascular risk factors in elderly adults. , 1995, European journal of clinical nutrition.

[114]  R. Bouillon,et al.  Structure-function relationships in the vitamin D endocrine system. , 1995, Endocrine reviews.

[115]  A. K. Jarvis,et al.  Inhibition of cardiac myocyte maturation by 1,25-dihydroxyvitamin D3. , 1995, Endocrinology.

[116]  R. Bouillon,et al.  1,25-Dihydroxyvitamin D3 Prevents Insulitis in NOD Mice , 1992, Diabetes.

[117]  L. Resnick.  Calcium Metabolism in Hypertension and Allied Metabolic Disorders , 1991, Diabetes Care.

[118]  M. Haussler,et al.  Identification and regulation of 1,25-dihydroxyvitamin D3 receptor activity and biosynthesis of 1,25-dihydroxyvitamin D3. Studies in cultured bovine aortic endothelial cells and human dermal capillaries. , 1989, The Journal of clinical investigation.

[119]  A. Fleck.  LATITUDE AND ISCHAEMIC HEART DISEASE , 1989, The Lancet.

[120]  J. Laragh,et al.  Calcium-regulating hormones in essential hypertension. Relation to plasma renin activity and sodium metabolism. , 1986, Annals of internal medicine.

[121]  R. Scragg.  Seasonality of cardiovascular disease mortality and the possible protective effect of ultra-violet radiation. , 1981, International journal of epidemiology.

[122]  G. Grodsky,et al.  Vitamin D deficiency inhibits pancreatic secretion of insulin. , 1980, Science.

[123]  H. DeLuca,et al.  Target cells for 1,25-dihydroxyvitamin D3 in intestinal tract, stomach, kidney, skin, pituitary, and parathyroid. , 1979, Science.